KIT in ovarian carcinoma: Disillusion about a potential therapeutic target [2]

Journal of the National Cancer Institute

Volumn 95, Issue 13, 2003, Pages 1009-1010

  Singer, Gad ^a   Schraml, Peter ^a   Belgard, Christopher ^a   Raggi, Anna ^a   Dirnhofer, Stephan ^a   Went, Philip ^a   Mihatsch, Michael J ^a   Moch, Holger ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MONOCLONAL ANTIBODY; ONCOPROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE KINASE RECEPTOR;

CANCER STAGING; CONTROLLED STUDY; DRUG TARGETING; EWING SARCOMA; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE ACTIVATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LETTER; MUTATIONAL ANALYSIS; ONCOGENE C KIT; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

EID: 0042308834     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.13.1009-a     Document Type: Letter

References (0)